report better-than-expect fiscal result strong revenu
million versu consensu expect million adjust
oper expans lower adjust tax rate drive meaning
out-performance adjust ep versu consensu expect
quarter compani achiev constant currenc organ growth
exceed forecast driven strength healthcar
product organ appli steril
estim notabl adjust gross margin
quarter particularli strong bp year-over-year
adjust oper expens higher percent sale
expect mostli relat higher incent compens given strength
quarter
ste combin order backlog healthcar life scienc product
increas year-over-year million end fiscal
compani healthcar equip order backlog remain healthi
year-over-year million end fiscal compani life
scienc backlog declin year-over-year million follow
robust quarter life scienc capit equip sale year-over-year
fiscal notabl manag also spoke posit order
pipelin beyond order backlog earn call
follow strong fiscal rais constant currenc organ
growth guidanc addit compani increas
adjust ep outlook along
reflect increas confid abil achiev least bp adjust
oper margin expans well slightli reduc adjust tax rate
rais adjust ep estim
new adjust ep forecast compani
deliv strong result across four divis fiscal
compani appear well posit maintain elev organ growth behind
favor market backdrop appli steril
encourag custom respons outsourc reprocess center
initi reiter buy rate increas price target
import pleas read disclosur disclaim page report
total debt total asset
report fiscal adjust ep consensu expect estim
better-than-anticip revenu adjust gross margin adjust incom tax contribut
upsid rel adjust ep forecast quarter
ste fiscal revenu increas year-over-year million well consensu
expect million estim million quarter compani achiev constant
currenc organ growth exceed forecast repres strongest
plcfiscal adjust incom statement revenu analysisnorthcoast research thousand except percentag per share gross sg sg oper oper interest expens incom incom tax incom margin incom com share growth ep growth life appli steril healthcar specialti compani report northcoast research estim factset busi unit perspect ste healthcar product divis achiev report constant currenc organ
growth posit fiscal forecast
quarter organ growth strong across healthcar product divis includ improv
roughli year-over-year healthcar consum driven steril assur instrument clean
chemistri v-pro consum year-over-year healthcar capit driven infect prevent
product infect prevent product continu drive ste healthcar capit growth
quarter continu expect oper room equip busi deliv improv perform
cours year behind hexavu integr system launch notabl ste healthcar equip order
backlog year-over-year million end fiscal suggest favor trend
steri plcorgan growth analysi benefit signific year-over-year increas shipment hurt difficult year-over-year comparison shipmentssourc compani report northcoast research plchealthcar product organ growth analysi benefit signific year-over-year increas shipment hurt difficult year-over-year comparison shipmentssourc compani report northcoast research continu next quarter compani also spoke posit visibl beyond backlog
order pipelin compani note improv demand new product help grow consum
sale
fiscal ste life scienc busi post organ growth well estim
time order contribut roughli increas life scienc capit organ growth quarter
compani life scienc consum sale also particularli strong approxim
organ expect life scienc custom work barrier product inventori fiscal
built prior brexit deadlin million rang sign
activ occur realiti custom like wait certainti brexit time impact
adjust inventori
ste appli steril ast busi achiev organ growth fiscal
well forecast addit strong medic devic market demand ste ast busi also
benefit capac expans slight custom inventori build ahead next brexit deadlin
modest market share gain relat disrupt creat forc mid-februari closur sterigen
ethylen oxid termin steril facil willowbrook illinoi moreov above-averag capit
spend addit ast capac expans think organ growth divis remain least
high-single-digit rang intermediate-term
steri plcorder backlog analysi northcoast researchord backlog order scienc order scienc compani report northcoast research estim aid black diamond video acquisitionsteri plclife scienc divis organ growth analysi compani report northcoast research
ste healthcar specialti servic busi achiev constant currenc organ growth fiscal
slightli forecast quarter compani suggest north american instrument
repair outsourc reprocess busi strong legaci synergi health busi
intern market grew low-single-digit rate notabl ste outsourc reprocess center busi
remain track would guess revenu increas approxim million roughli
million moreov outsourc reprocess center busi continu ramp think
good visibl ste healthcar specialti servic divis continu double-digit grower
ste fiscal adjust oper margin increas bp year-over-year
estim quarter adjust gross margin particularli strong bp year-over-year
higher performance-bas compens contribut increas adjust oper expens
percent sale notabl favor volum price growth bp year-over-year fiscal versu
ste posit bp expect year contribut ste improv gross margin quarter
divis standpoint ast healthcar product drove increas ste fiscal adjust
plcappli steril technolog divis organ growth analysissourc compani report northcoast research plchealthcar specialti servic divis organ growth analysissourc compani report northcoast research oper margin robust sale lower-margin capit product weigh life scienc oper margin
perform quarter
follow strong fiscal rais constant currenc organ growth guidanc
addit compani increas adjust ep outlook along
improv organ growth outlook ste higher adjust ep guidanc also reflect increas confid
abil achiev least bp adjust oper margin expans well slightli reduc adjust tax
rate assumpt versu previous rais adjust ep estim
new adjust ep forecast compani
summari deliv strong result across four divis fiscal compani appear well
posit maintain elev organ growth behind healthi healthcar capit backlog strong healthcar
product launch activ favor market backdrop appli steril encourag
custom respons outsourc reprocess center initi reiter buy rate
increas price target
plcadjust oper margin healthcar life appli steril healthcar specialti fiscal exclud corpor expensesourc compani report northcoast research
steri plcannual incom statement analysi adjust northcoast research thousand except percent per share gross gross sg sg oper oper net interest expens interest net expens incom incom incom tax minor net incom extra net margin extra extra net incom continu net wghd com share ep ep revenu growth adjust ep growth compani report northcoast research estim result adjust reflect adopt disclosur
